Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Conditions:   Platinum-Resistant Fallopian Tube Carcinoma;   Platinum-Resistant Primary Peritoneal Carcinoma;   PARP Inhibitor;   Hedgehog Inhibitor Interventions:   Drug: Vismodegib;   Drug: Atezolizumab Sponsors:   Ronald Buckanovich;   Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials